Chemocentryx Inc (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 32,224 | 64,891 | 36,128 | 42,875 | 82,497 |
| Cost of Goods | 302 | N/A | N/A | N/A | N/A |
| Gross Profit | 31,922 | 64,891 | 36,128 | 42,875 | 82,497 |
| Operating Expenses | 162,143 | 120,068 | 94,431 | 83,145 | 66,004 |
| Operating Income | -129,919 | -55,177 | -58,303 | -40,270 | 16,493 |
| Interest Expense | 2,695 | 2,643 | 2,149 | 1,224 | 4 |
| Other Income | 859 | 2,464 | 4,963 | 3,528 | 1,370 |
| Pre-tax Income | -131,755 | -55,356 | -55,489 | -37,966 | 17,859 |
| Net Income Continuous | -131,755 | -55,356 | -55,489 | -37,966 | 17,859 |
| Net Income | $-131,755 | $-55,356 | $-55,489 | $-37,966 | $17,859 |
| EPS Basic Total Ops | -1.89 | -0.84 | -0.98 | -0.76 | 0.37 |
| EPS Basic Continuous Ops | -1.89 | -0.84 | -0.98 | -0.76 | 0.37 |
| EPS Diluted Total Ops | -1.89 | -0.84 | -0.98 | -0.76 | 0.36 |
| EPS Diluted Continuous Ops | -1.89 | -0.84 | -0.98 | -0.76 | 0.36 |
| EPS Diluted Before Non-Recurring Items | -1.89 | -0.84 | -0.98 | -0.76 | 0.36 |
| EBITDA(a) | $-126,780 | $-54,380 | $-57,753 | $-39,758 | $16,911 |